Connecticut Proton Therapy Center selects RayCare
The Connecticut Proton Therapy Center will be the first of its kind in the state of
RayCare will be Connecticut Proton Therapy Center's only oncology information system and will be utilized with the ProteusONE proton system. The center will use the workflow engine of RayCare for creating clinic specific workflows, with the aim of a complete clinical implementation in 2026, when the center opens. RayCare will also be used together with RaySearch's treatment planning system RayStation, which was acquired in 2023.
Johan Löf, founder and CEO, RaySearch, says: "We are happy to welcome yet another RayCare customer. For our installed base of RayStation customers the selection of RayCare as oncology information system will enhance efficiency and user experience, both in the treatment planning process and treatment delivery."
Revenue from the order is expected to be recognized during 2025.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
* Subject to regulatory clearance in some markets.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
RaySearch Press Release | |
RayCare-Connecticut Proton Therapy Center 1200x620 |
View original content:https://www.prnewswire.com/news-releases/connecticut-proton-therapy-center-selects-raycare-302227390.html
SOURCE RaySearch Laboratories
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Progress -- XellSmart Unveiled Phase I Results of Off-the-Shelf Parkinson's Disease Cell Therapy at MDS & Completed Blinded Phase II Enrollment
- Top 3 Cryptos to Buy Now: Remittix, Solana and XRP as Alpenglow Nears and RLUSD Enters Core Banking
- Pepe Coin Price Prediction: PEPE Trades Near $0.0000040 as Remittix’s PayFi Tests Put Utility Back in Focus
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share